Area of research
Reproductive Medicine · Cancer Research
Research interest
Research focused on Prostate cancer and Bladder cancer, with related work in Cancer research, Gut flora, Inflammation. Notable publications include 'Circular RNA circBbs9 promotes PM2.5-induced lung inflammation in mice via NLRP3 inflammasome activation', 'Early diagenetic control on the enrichment and fractionation of rare earth elements in deep-sea sediments', and 'Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization'.
Local Coordination Environment-Driven Structural Dynamics of Single-Atom Copper and the CO<sub>2</sub> Electroreduction Pathway
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC
Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization
Integrated single‐cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial–fibroblast interactions in recurrent bladder cancer
Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment
Identification of a novel ferroptosis-inducing micropeptide in bladder cancer
Early diagenetic control on the enrichment and fractionation of rare earth elements in deep-sea sediments
Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways
Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer
Circular RNA circ_Cabin1 promotes DNA damage in multiple mouse organs via inhibition of non-homologous end-joining repair upon PM2.5 exposure
Circular RNA circBbs9 promotes PM2.5-induced lung inflammation in mice via NLRP3 inflammasome activation
Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer